Moreover, transient knockdown of ERα in luminal-like breast cancer MCF-7 cells rendered the cells ∼20-fold less sensitive to AFP464 compared to siRNA-negative control cells (IC50, 0.20 versus 0.01 μM). Here, ESR1 is linked to breast carcinoma.